Voluntary Pricing and Access Scheme negotiating team
The Voluntary Pricing and Access Scheme (VPAS) negotiating team was led by Steve Oldfield at the Department of Health and Social Care (DHSC) and consisted of a joint team of colleagues from DHSC, NHSE and the Complex Transactions Team (CTT) in the Cabinet Office.
The team delivered a market-leading deal to accelerate the uptake of new innovative medicines to NHS patients, up to six months earlier and within an affordable financial envelope. The voluntary scheme is designed to keep growth in the branded medicine bill predictable and affordable by placing a 2% cap per annum on the growth in sales of branded medicines to the NHS, over a five year period.
The savings from the drugs budget will be used to deliver more critical frontline services. This is a win for patients, a pre-Brexit win for the pharmaceutical industry and a cost reduction for tax payers.